Literature DB >> 16353541

[Evaluation of K-ras 12 oncogene mutations in Venezuelan patients with Helicobacter pylori infection].

Patrizzia Mastromatteo1, María Correnti, María Eugenia Cavazza, Marianella Perrone, Claudio Tombazzi, Víctor Lecuna.   

Abstract

This work evaluated the infection of H. pylori in the different gastric pathologies and its association with the oncogen K-ras 12. Endoscopy was performed in 62 patients and 3 biopsies from the antral region were taked and used for the histological diagnostic, PCR, and point mutations determination. The results showed a high incidence of H. pylori infection in patients with active chronic gastritis (AcCG) 90%, chronic atrophic gastritis (AtCG) 70%, intestinal metaplasia (IM) 67%, dysplasia (D) 83%, and decrease in in gastric cancer (GC) 33%. Evaluation of the oncogen K-ras 12 showed that 68% of the patients presented mutations in the different analyzed amino acids. In the 12 codon of the K-ras gene, we observed simple point mutations and combination in the same sample in different gastric pathologies. In AcCG samples were detected the greater number of mutations. A decrease of the point mutations were observed in the progression stages to gastric cancer. The presence of these specific mutations would be tumor markers and it determine the possible development of gastric tumors.

Entities:  

Mesh:

Year:  2005        PMID: 16353541

Source DB:  PubMed          Journal:  Invest Clin        ISSN: 0535-5133            Impact factor:   0.683


  2 in total

Review 1.  Mutational landscape of gastric adenocarcinoma in Latin America: A genetic approach for precision medicine.

Authors:  Dennis Cerrato-Izaguirre; Yolanda I Chirino; Claudia M García-Cuellar; Miguel Santibáñez-Andrade; Diddier Prada; Angélica Hernández-Guerrero; Octavio Alonso Larraga; Javier Camacho; Yesennia Sánchez-Pérez
Journal:  Genes Dis       Date:  2021-04-24

2.  Analysis of KRAS gene mutation associated with Helicobacter pylori infection in patients with gastric cancer.

Authors:  Raheleh Jabini; Seyed Ahmad Eghbali; Hossein Ayatollahi; Maryam Sheikhi; Mohammadreza Farzanehfar
Journal:  Iran J Basic Med Sci       Date:  2019-05       Impact factor: 2.699

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.